SLI
1.978,78
PKT
+6,72
PKT
+0,34
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.07.25 | Richemont Buy | Jefferies & Company Inc. | |
| 15.07.25 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
| 14.07.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 14.07.25 | Richemont Hold | Deutsche Bank AG | |
| 14.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.07.25 | Swiss Re Buy | UBS AG | |
| 11.07.25 | Zurich Insurance Sell | UBS AG | |
| 10.07.25 | UBS Buy | Deutsche Bank AG | |
| 10.07.25 | Roche Buy | UBS AG | |
| 09.07.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 09.07.25 | ams-OSRAM Buy | Deutsche Bank AG | |
| 09.07.25 | Richemont Outperform | Bernstein Research | |
| 09.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 08.07.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 08.07.25 | Richemont Outperform | Bernstein Research | |
| 08.07.25 | Roche Sell | Deutsche Bank AG | |
| 08.07.25 | Givaudan Equal Weight | Barclays Capital | |
| 07.07.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.07.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 04.07.25 | Novartis Buy | Deutsche Bank AG | |
| 04.07.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.07.25 | Novartis Neutral | UBS AG | |
| 03.07.25 | UBS Outperform | RBC Capital Markets | |
| 03.07.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 02.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | Zurich Insurance Sell | Goldman Sachs Group Inc. | |
| 01.07.25 | Nestlé Hold | Deutsche Bank AG | |
| 01.07.25 | Richemont Sector Perform | RBC Capital Markets | |
| 01.07.25 | Roche Buy | UBS AG | |
| 01.07.25 | Novartis Neutral | UBS AG | |
| 30.06.25 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.06.25 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 30.06.25 | UBS Buy | Jefferies & Company Inc. | |
| 30.06.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.06.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 27.06.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 27.06.25 | ams-OSRAM Buy | UBS AG | |
| 27.06.25 | Richemont Outperform | Bernstein Research |